Drugs / PRX-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02554396 | Sep → Nov 2015 | presbyopia | LENZ Therapeutics, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRX-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02554396 ↗ |
| Route | Topical | “ophthalmic topical formulation” NCT02554396 ↗ |